Distribution and Synthesis of Apolipoprotein J in the Atherosclerotic Aorta
Authors:
- 1 April 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 18 (4) , 665-672
Abstract
Abstract— The distribution of apolipoprotein (apo) J during the development of atherosclerosis in the human aorta was evaluated by immununohistochemical observation, together with the other apolipoprotein A-I, A-II, B, C-III, and E. Although apoJ was never observed in the normal aorta (ie, without any intimal lesions or intimal thickening), it was distributed not only in the intima but also in the media of aortas with diffuse, intimal thickening or atherosclerotic lesions. Double immunostaining with antibodies for apoJ and α-smooth muscle actin revealed apoJ deposition in smooth muscle cells (SMCs) or the aortic stroma in the vicinity of SMCs. The extent of apoJ distribution in the aortic wall increased with the degree of atherosclerosis development. In addition, the distribution pattern of apoJ was very similar to that of apoA-I and E. In situ hybridization with human apoJ cDNA demonstrated intense signals in cells scattered within the subendothelial space and medial SMCs of the aorta with advanced atherosclerosis but not in those of the normal aorta without intimal thickening. Furthermore, reverse transcriptase–polymerase chain reaction of the cultured human aortic SMCs revealed apoJ mRNA expression in these cells. The results indicate that apoJ in the aortic wall originates from not only apoJ circulated in the plasma but also apoJ produced by SMCs in the aortic wall. Considering the similarities of the distribution between apoJ and apo-A-I or E, we hypothesize that apoJ possibly has a protective role against human atherosclerosis by its involvement with cholesterol transport from the aortic wall to the liver.Keywords
This publication has 32 references indexed in Scilit:
- Assignment of a human serum glycoprotein SP-40,40 gene (CLI) to chromosome 8Cytogenetic and Genome Research, 1991
- Incorporation of SP-40,40 into the solyble membrance attack complex(SMAC, SC5b-9) of complementInternational Immunology, 1990
- Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.Journal of Clinical Investigation, 1990
- Gene expression in response to acute unilateral ureteral obstructionKidney International, 1989
- Localization of terminal complement components, S-protein and SP-40,40 in renal biopsiesPathology, 1989
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Apolipoprotein E gene mapping and expression: localization of the structural gene to human chromosome 19 and expression of ApoE mRNA in lipoprotein- and non-lipoprotein-producing tissuesBiochemistry, 1985
- Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery DiseaseNew England Journal of Medicine, 1983
- Current concepts of the molecular structure and metabolism of human apolipoproteins and lipoproteinsJournal of Molecular Medicine, 1981
- Fractionation of human serum high density lipoprotein in urea solutions. Evidence for polypeptide heterogeneityBiochemistry, 1969